Closing Bell: Knight Therapeutics Inc down on Wednesday (GUD)

Today in trading, Knight Therapeutics Inc shares opened at $5.75 and closed at $5.74. Intraday prices ranged from $5.69 to $5.82.

Share prices decreased -0.86% from the previous day's close of $5.79.

Today across North America, the TSX Composite closed 1.07% at 22995.39, the S&P 500 closed 0.64% at 5667.20, the Dow Jones Industrial Average closed 1.85% at 40954.48 and the Nasdaq Composite closed 0.20% at 18509.34.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

Trading volume was 53,713 on 252 total trades, while having an average volume of 45,551 over the last 5-days.

Trading across the entire TSX saw 2,100 price advancers against 3,108 declines and 117 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, the shares have boosted 17.62 percent in the last year, while they have advanced 10.60% since the start of 2024.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $586.97 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc has an average recommendation of "Moderate Buy" based on 4.00 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..